Nucleic Acids Research, 2002, Vol. 30, No. 11 2427-2434
© 2002 Oxford University Press
Interactions between p53, hMSH2–hMSH6 and HMG I(Y) on Holliday junctions and bulged bases
Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, CB 7295 Mason Farm Road, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA
The ability of the tumor suppressor protein, p53, to recognize certain types of DNA lesions may represent one of the mechanisms by which this protein modulates cellular response to DNA damage. p53 DNA binding properties are regulated by several factors, such as post-translational modifications including phosphorylation and acetylation, regulation by its own C-terminal domain and interactions with other cellular proteins. Substrates resembling Holliday junctions and extra base bulges were used to study the effect of three nuclear proteins, HMG-1, HMG I(Y) and hMSH2–hMSH6, on the lesion binding properties of p53. Gel retardation assays revealed that the three proteins had varying effects on p53 binding to these substrates. HMG-1 did not influence p53 binding to Holliday junctions or 3-cytosine bulges. HMG I(Y) rapidly dissociated p53 complexes with Holliday junctions but not 3-cytosine bulges. Finally, the mismatch repair protein complex, hMSH2–hMSH6, enhanced p53 binding to both substrates by 3–4-fold. Together, these results demonstrate that p53 DNA binding activity is highly influenced by the presence of other proteins, some having a dominant effect while others have a negative effect.
* To whom correspondence should be addressed. Tel: +1 919 966 2151; Fax: +1 919 966 3015; Email: jdg{at}med.unc.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Subramanian and J. D. Griffith p53 Monitors Replication Fork Regression by Binding to "Chickenfoot" Intermediates J. Biol. Chem., December 30, 2005; 280(52): 42568 - 42572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Walter, G. Warnecke, R. Bowater, W. Deppert, and E. Kim Tumor Suppressor p53 Binds with High Affinity to CTG{middle dot}CAG Trinucleotide Repeats and Induces Topological Alterations in Mismatched Duplexes J. Biol. Chem., December 30, 2005; 280(52): 42497 - 42507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Boehden, A. Restle, R. Marschalek, C. Stocking, and L. Wiesmuller Recombination at chromosomal sequences involved in leukaemogenic rearrangements is differentially regulated by p53 Carcinogenesis, August 1, 2004; 25(8): 1305 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Hommura, M. Katabami, V. D. Leaner, H. Donninger, T. F. Sumter, L. M.S. Resar, and M. J. Birrer HMG-I/Y Is a c-Jun/Activator Protein-1 Target Gene and Is Necessary for c-Jun-Induced Anchorage-Independent Growth in Rat1a Cells Mol. Cancer Res., May 1, 2004; 2(5): 305 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Di Agostino, M. Fedele, P. Chieffi, A. Fusco, P. Rossi, R. Geremia, and C. Sette Phosphorylation of High-Mobility Group Protein A2 by Nek2 Kinase during the First Meiotic Division in Mouse Spermatocytes Mol. Biol. Cell, March 1, 2004; 15(3): 1224 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Phosphorylation State of p53 Alters its DNA Damage Recognition Properties: DEEPA SUBRAMANIAN AND JACK D. GRIFFITH, Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 Toxicol Pathol, January 1, 2004; 32(1): 158 - 158. [PDF]
|
|